Literature DB >> 19633676

Interventional cardiology: A new drug-eluting stent that does not live up to its promise.

David R Holmes.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19633676     DOI： 10.1038/nrcardio.2009.117

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  8 in total

1.  Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.

Authors:  Sjoerd H Hofma; Wim J van der Giessen; Bas M van Dalen; Pedro A Lemos; Eugene P McFadden; Georgios Sianos; Jurgen M R Ligthart; Dirk van Essen; Pim J de Feyter; Patrick W Serruys
Journal:  Eur Heart J       Date:  2005-10-25       Impact factor: 29.983

Review 2.  Coronary-artery stents.

Authors:  Patrick W Serruys; Michael J B Kutryk; Andrew T L Ong
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

3.  Clinical end points in coronary stent trials: a case for standardized definitions.

Authors:  Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; P Gabriel Steg; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick W Serruys
Journal:  Circulation       Date:  2007-05-01       Impact factor: 29.690

4.  Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.

Authors:  Henri Roukoz; Anthony A Bavry; Michael L Sarkees; Girish R Mood; Dharam J Kumbhani; Mark G Rabbat; Deepak L Bhatt
Journal:  Am J Med       Date:  2009-06       Impact factor: 4.965

5.  Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.

Authors:  Stephan Windecker; Patrick W Serruys; Simon Wandel; Pawel Buszman; Stanislaw Trznadel; Axel Linke; Karsten Lenk; Thomas Ischinger; Volker Klauss; Franz Eberli; Roberto Corti; William Wijns; Marie-Claude Morice; Carlo di Mario; Simon Davies; Robert-Jan van Geuns; Pedro Eerdmans; Gerrit-Anne van Es; Bernhard Meier; Peter Jüni
Journal:  Lancet       Date:  2008-08-31       Impact factor: 79.321

6.  Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents.

Authors:  Brendan Doyle; Charanjit S Rihal; Crochan J O'Sullivan; Ryan J Lennon; Heather J Wiste; Malcolm Bell; John Bresnahan; David R Holmes
Journal:  Circulation       Date:  2007-11-05       Impact factor: 29.690

7.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

8.  MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses.

Authors:  Yoshinobu Onuma; Patrick Serruys; Peter den Heijer; Kaiyum Sheik Joesoef; Henricus Duckers; Evelyn Regar; Neville Kukreja; Shuzou Tanimoto; Hector M Garcia-Garcia; Heleen van Beusekom; Willem van der Giessen; Takuji Nishide
Journal:  Eur Heart J       Date:  2009-04-30       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.